Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs061220073Recruiting
Open-label, single-arm trial of olanexidine in Infection, sponsored by Hiroshima Rotary Club. Primary endpoint: Blood culture contamination rate. Started Feb 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs061220073.